Meet Antonio

World Diabetes Month
Antonio is a 49 years young resident of New York City, living with type 2 diabetes. He was diagnosed a little over three years ago after a routine check-up with his primary care physician.
While Antonio wasn’t expecting the diagnosis, it wasn’t a complete shock either, as he had lost his mother to diabetes.
Continue reading “Meet Antonio”

Effect of Violence on Healthcare

Deliberate, calculated attacks on healthcare facilities have become a routine weapon of war. These assaults kill both patients and health workers, and they devastate already vulnerable health systems. Not to mention they violate the Geneva Conventions.

In 2017, there were at least 701 attacks on hospitals, health workers, patients, and ambulances in 23 countries in conflict around the world. More than 101 health workers and 293 patients and others are reported to have died as a result of these attacks. The 2017 report, compiled by the Safeguarding Health in Conflict Coalition, only includes events that occurred in the context of armed conflicts or situations of severe political volatility.
Continue reading “Effect of Violence on Healthcare”

Prescription of generic drugs

18 years ago Brazil welcomed the country’s first generic drug registration. According to the National Agency for Sanitary Vigilance Agency (Anvisa), prescription of generic drugs increased 65% from 2015 to 2018. Between February of last year and February of this year, 34% of the 115 million medical prescriptions issued were generic versions.
Continue reading “Prescription of generic drugs”

State lawmakers and prescription drug

This year, state lawmakers across the U.S. have introduced an unprecedented 160 bills to stem the rising cost of prescription drugs, and have enacted 37 into law.

States are pursuing a range of strategies to tackle drug costs including

  • allowing pharmacists to share lower cost drug options with consumers,
  • enacting laws that authorize the wholesale purchase of drugs from Canada,
  • and requiring drug manufacturers to provide additional data justifying price increases over specified thresholds.

For the past several years there has been increased interest and activity on legislation that relates to the pricing, payment, and costs associated with prescription drugs. Can more be done?

You can find below what the M3 Global Research community answered to this question.

Let us hear your opinion on this by signing up to receive the Monthly Pulse via email and to take part in paid medical studies.

 

Brexit and the delay in the supply of medicines

Earlier this year, the Brexit Health Alliance published a paper calling on both the UK and EU to put patients first.

It warned that unless a deal can be reached, medicines and medical technologies could be delayed or, in extreme cases, become unavailable to patients.

The Alliance is concerned that if a decision can’t be reached regarding the future co-operation between the UK and the EU on the regulation and trade of medicines and medical devices that up to 120,000 prostate cancer patients throughout Europe could be affected.

Another area at risk is the future of research into new medicines and medical technologies. Without a plan in place, UK and EU patients could lose out on access to the best treatments and medical devices.

Are you concerned about the impact of Brexit? 
You can find below what the M3 Global Research community answered to this question.

Let us hear your opinion on this by signing up to receive the Monthly Pulse via email and to take part in paid medical studies.